Scenarios that move TVTX

Travere Therapeutics, Inc. - Common Stock

Scenarios that move TVTX: 2 analyses, 1 positive, 1 negative.

1. 2026-10-13 · Mirum's Livmarli meets Phase III goal in ultra-rare liver diseases — ▲ · impact +14 · confidence low · horizon quarters
2. 2026-09-23 · Ionis reports positive late-stage results for two partnered drugs — ▼ · impact -42 · confidence low · horizon immediate

All scenarios · Run a scenario · Pricing